{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:31:25Z","timestamp":1778833885032,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10072-017-3077-4","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T07:19:59Z","timestamp":1501917599000},"page":"1913-1920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evidence for association between hepatitis C virus and Parkinson\u2019s disease"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1399-6487","authenticated-orcid":false,"given":"Abdelrahman Ibrahim","family":"Abushouk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa Wanees Ahmed","family":"El-Husseny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayar","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attia","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussien","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravikishore","family":"Pallanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Negida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"key":"3077_CR1","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744\u20131754","journal-title":"J Clin Invest"},{"key":"3077_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci 28:57\u201387","journal-title":"Annu Rev Neurosci"},{"key":"3077_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376. doi: 10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3077_CR4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LML Lau De","year":"2006","unstructured":"De Lau LML, Breteler MMB (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535","journal-title":"Lancet Neurol"},{"key":"3077_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.biopha.2017.03.100","volume":"90","author":"H Ahmed","year":"2017","unstructured":"Ahmed H, Abushouk AI, Gabr M, Negida A, Abdel-Daim MM (2017) Parkinson\u2019s disease and pesticides: a meta-analysis of disease connection and genetic alterations. Biomed Pharmacother 90:638\u2013649","journal-title":"Biomed Pharmacother"},{"key":"3077_CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7883\/yoken.52.89","volume":"52","author":"M Takahashi","year":"1999","unstructured":"Takahashi M, Yamada T (1999) Viral etiology for Parkinson\u2019s disease\u2014a possible role of influenza A virus infection. Jpn J Infect Dis 52:89\u201398","journal-title":"Jpn J Infect Dis"},{"key":"3077_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000114785","volume":"15","author":"RJ Marttila","year":"1977","unstructured":"Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK (1977) Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol 15:25\u201333","journal-title":"Eur Neurol"},{"key":"3077_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"The Polaris Observatory HCV collaborators","year":"2017","unstructured":"The Polaris Observatory HCV collaborators (2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol & Hepatol 2:161\u2013176","journal-title":"Lancet Gastroenterol & Hepatol"},{"key":"3077_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","volume":"138","author":"GL Davis","year":"2010","unstructured":"Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW (2010) Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138:513\u2013521, 521.e1\u20136. doi: 10.1053\/j.gastro.2009.09.067","journal-title":"Gastroenterology"},{"key":"3077_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cld.2008.03.007","volume":"12","author":"W Blonski","year":"2008","unstructured":"Blonski W, Reddy KR (2008) Hepatitis C virus infection and hepatocellular carcinoma. Clin Liver Dis 12:661\u2013674. doi: 10.1016\/j.cld.2008.03.007","journal-title":"Clin Liver Dis"},{"key":"3077_CR11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s004150050388","volume":"246","author":"JG Heckmann","year":"1999","unstructured":"Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neund\u00f6rfer B (1999) Neurological manifestations of chronic hepatitis C. J Neurol 246:486\u2013491","journal-title":"J Neurol"},{"key":"3077_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","volume":"19","author":"D S\u00e8ne","year":"2004","unstructured":"S\u00e8ne D, Limal N, Cacoub P (2004) Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 19:357\u2013381","journal-title":"Metab Brain Dis"},{"issue":"Suppl 3","key":"3077_CR13","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/01.aids.0000192083.41561.00","volume":"19","author":"T Laskus","year":"2005","unstructured":"Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J (2005) Emerging evidence of hepatitis C virus neuroinvasion. AIDS 19(Suppl 3):S140\u2013S144","journal-title":"AIDS"},{"key":"3077_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/jvh.12392","volume":"22","author":"WY-Y Wu","year":"2015","unstructured":"Wu WY-Y, Kang K-H, Chen SL-S, Chiu SY-H, Yen AM-F, Fann JC-Y et al (2015) Hepatitis C virus infection: a risk factor for Parkinson\u2019s disease. J Viral Hepat 22:784\u2013791. doi: 10.1111\/jvh.12392","journal-title":"J Viral Hepat"},{"key":"3077_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1212\/WNL.0000000000002307","volume":"86","author":"H-H Tsai","year":"2016","unstructured":"Tsai H-H, Liou H-H, Muo C-H, Lee C-Z, Yen R-F, Kao C-H (2016) Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study. Neurology 86:840\u2013846. doi: 10.1212\/WNL.0000000000002307","journal-title":"Neurology"},{"key":"3077_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNF.0000000000000120","volume":"39","author":"KJ Wangensteen","year":"2016","unstructured":"Wangensteen KJ, Krawitt EL, Hamill RW, Boyd JT (2016) Parkinsonism in patients with chronic hepatitis C treated with interferons. Clin Neuropharmacol 39:1\u20135. doi: 10.1097\/WNF.0000000000000120","journal-title":"Clin Neuropharmacol"},{"key":"3077_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2000-9503","volume":"20","author":"EJ Gowans","year":"2000","unstructured":"Gowans EJ (2000) Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis 20:85\u2013102","journal-title":"Semin Liver Dis"},{"key":"3077_CR18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/JVI.76.2.600-608.2002","volume":"76","author":"M Radkowski","year":"2002","unstructured":"Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C et al (2002) Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76:600\u2013608","journal-title":"J Virol"},{"key":"3077_CR19","unstructured":"Adair DM, Wilkinson J, Scheck AC, Radkowski M, Rakela J, Laskus T (2004) Differential display and microarray analysis show differentially expressed genes in central nervous system in HCV infected patients and laser capture microscopy points to brain microglia as cells harboring HCV. Hepatology, vol. 40, John Wiley & Sons Inc 111 River St, Hoboken, NJ 07030 USA, p. 433A"},{"key":"3077_CR20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","volume":"142","author":"NF Fletcher","year":"2012","unstructured":"Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM et al (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142:634\u2013643.e6","journal-title":"Gastroenterology"},{"key":"3077_CR21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/1570163811666140212112300","volume":"11","author":"G Lucchese","year":"2014","unstructured":"Lucchese G, Kanduc D (2014) Single amino acid repeats connect viruses to neurodegeneration. Curr Drug Discov Technol 11:214\u2013219","journal-title":"Curr Drug Discov Technol"},{"key":"3077_CR22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","volume":"117","author":"L Qian","year":"2010","unstructured":"Qian L, Flood PM, Hong J-S (2010) Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy. J Neural Transm 117:971\u2013979","journal-title":"J Neural Transm"},{"key":"3077_CR23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(00)05270-3","volume":"358","author":"DM Forton","year":"2001","unstructured":"Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38\u201339","journal-title":"Lancet"},{"key":"3077_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1098-1136(199802)22:2<103::AID-GLIA1>3.0.CO;2-8","volume":"22","author":"PD Lyons","year":"1998","unstructured":"Lyons PD, Benveniste EN (1998) Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia 22:103\u2013112","journal-title":"Glia"},{"key":"3077_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/md6010025","volume":"6","author":"SS Gill","year":"2008","unstructured":"Gill SS, Hou Y, Ghane T, Pulido OM (2008) Regional susceptibility to domoic acid in primary astrocyte cells cultured from the brain stem and hippocampus. Mar Drugs 6:25\u201338","journal-title":"Mar Drugs"},{"key":"3077_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/glia.22272","volume":"60","author":"GK Sheridan","year":"2012","unstructured":"Sheridan GK, Dev KK (2012) S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia 60:382\u2013392. doi: 10.1002\/glia.22272","journal-title":"Glia"},{"key":"3077_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pathophys.2012.02.003","volume":"20","author":"M Fiala","year":"2013","unstructured":"Fiala M, Avagyan H, Merino JJ, Bernas M, Valdivia J, Espinosa-Jeffrey A et al (2013) Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy. Pathophysiol: Off J Int Soc Pathophysiol 20:59\u201369. doi: 10.1016\/j.pathophys.2012.02.003","journal-title":"Pathophysiol: Off J Int Soc Pathophysiol"},{"key":"3077_CR28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1128\/JVI.74.3.1415-1424.2000","volume":"74","author":"TE Lane","year":"2000","unstructured":"Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD et al (2000) A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74:1415\u20131424","journal-title":"J Virol"},{"key":"3077_CR29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3844\/ajidsp.2009.314.319","volume":"5","author":"C Chao","year":"2009","unstructured":"Chao C, Ghorpade A (2009) Production and roles of glial tissue inhibitor of metalloproteinases-1 in human immunodeficiency virus-1-associated dementia neuroinflammation: a review. Am J Infect Dis 5:314\u2013320","journal-title":"Am J Infect Dis"},{"key":"3077_CR30","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.127re6","volume":"1","author":"WG Stetler-Stevenson","year":"2008","unstructured":"Stetler-Stevenson WG (2008) Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Science Signaling 1:re6. doi: 10.1126\/scisignal.127re6","journal-title":"Science Signaling"},{"key":"3077_CR31","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gut.2005.080267","volume":"55","author":"K Weissenborn","year":"2006","unstructured":"Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H et al (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 55:1624\u20131630. doi: 10.1136\/gut.2005.080267","journal-title":"Gut"},{"key":"3077_CR32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJM198612183152503","volume":"315","author":"JH Hoofnagle","year":"1986","unstructured":"Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M et al (1986) Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 315:1575\u20131578","journal-title":"N Engl J Med"},{"key":"3077_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMp1400986","volume":"370","author":"RT Chung","year":"2014","unstructured":"Chung RT, Baumert TF (2014) Curing chronic hepatitis C\u2014the arc of a medical triumph. N Engl J Med 370:1576\u20131578. doi: 10.1056\/NEJMp1400986","journal-title":"N Engl J Med"},{"key":"3077_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3329\/bjp.v12i1.29940","volume":"12","author":"H Ahmed","year":"2017","unstructured":"Ahmed H, Abushouk AI, Gadelkarim M, Mohamed A, Gabr M, Negida A (2017) Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection. Bangladesh J Pharmacol 12:12\u201322","journal-title":"Bangladesh J Pharmacol"},{"key":"3077_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","volume":"19","author":"CL Raison","year":"2005","unstructured":"Raison CL, Demetrashvili M, Capuron L, Miller AH (2005) Neuropsychiatric adverse effects of interferon-\u03b1. CNS Drugs 19:105\u2013123","journal-title":"CNS Drugs"},{"key":"3077_CR36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.20049","volume":"19","author":"JS LaRochelle","year":"2004","unstructured":"LaRochelle JS, Karp BI (2004) Restless legs syndrome due to interferon-\u03b1. Mov Disord 19:730\u2013731","journal-title":"Mov Disord"},{"key":"3077_CR37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/mds.21302","volume":"22","author":"LC Quarantini","year":"2007","unstructured":"Quarantini LC, Miranda-Scippa A, Parana R, Sampaio AS, Bressan RA (2007) Acute dystonia after injection of pegylated interferon alpha-2b. Mov Disord 22:747\u2013748","journal-title":"Mov Disord"},{"key":"3077_CR38","first-page":"54","volume":"37","author":"Y Mizoi","year":"1997","unstructured":"Mizoi Y, Kaneko H, Oharazawa A, Kuroiwa H (1997) Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C. Rinsho Shinkeigaku 37:54\u201356","journal-title":"Rinsho Shinkeigaku"},{"key":"3077_CR39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0006-8993(96)01371-6","volume":"747","author":"H Shuto","year":"1997","unstructured":"Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R (1997) Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747:348\u2013351","journal-title":"Brain Res"},{"key":"3077_CR40","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R et al (2007) Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27:3328\u20133337. doi: 10.1523\/JNEUROSCI.5321-06.2007","journal-title":"J Neurosci"},{"key":"3077_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182\u2013192. doi: 10.1172\/JCI36470","journal-title":"J Clin Invest"},{"key":"3077_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1590\/S0004-282X2009000400031","volume":"67","author":"CMO Almeida De","year":"2009","unstructured":"De Almeida CMO, Galv\u00e3o MDLDS, Ferreira PLDC, Braga WS (2009) Interferon-induced parkinsonism in a patient with chronic hepatitis C. Arq Neuropsiquiatr 67:715\u2013716. doi: 10.1590\/S0004-282X2009000400031","journal-title":"Arq Neuropsiquiatr"},{"key":"3077_CR43","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s10072-016-2663-1","volume":"37","author":"HC \u00c7ubuk\u00e7u","year":"2016","unstructured":"\u00c7ubuk\u00e7u HC, Yurtda\u015f M, Durak ZE, Ayta\u00e7 B, G\u00fcne\u015f HN, \u00c7okal BG et al (2016) Oxidative and nitrosative stress in serum of patients with Parkinson\u2019s disease. Neurol Sci 37:1793\u20131798. doi: 10.1007\/s10072-016-2663-1","journal-title":"Neurol Sci"},{"key":"3077_CR44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","volume":"36","author":"E Ak\u0131l","year":"2015","unstructured":"Ak\u0131l E, Bulut A, Kaplan \u0130, \u00d6zdemir HH, Arslan D, Alu\u00e7lu MU (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil\/lymphocyte ratio in Parkinson\u2019s disease. Neurol Sci 36:423\u2013428. doi: 10.1007\/s10072-014-1976-1","journal-title":"Neurol Sci"},{"key":"3077_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10072-016-2758-8","volume":"38","author":"C Ata\u00e7 U\u00e7ar","year":"2017","unstructured":"Ata\u00e7 U\u00e7ar C, G\u00f6k\u00e7e \u00c7okal B, \u00dcnal Art\u0131k HA, \u0130nan LE, Yolda\u015f TK (2017) Comparison of neutrophil\u2013lymphocyte ratio (NLR) in Parkinson\u2019s disease subtypes. Neurol Sci 38:287\u2013293. doi: 10.1007\/s10072-016-2758-8","journal-title":"Neurol Sci"},{"key":"3077_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","volume":"62","author":"JM Taylor","year":"2013","unstructured":"Taylor JM, Main BS, Crack PJ (2013) Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease. Neurochem Int 62:803\u2013819. doi: 10.1016\/j.neuint.2012.12.016","journal-title":"Neurochem Int"},{"key":"3077_CR47","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1042\/BST0351127","volume":"35","author":"ML Block","year":"2007","unstructured":"Block ML, Hong J-S (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35:1127\u20131132. doi: 10.1042\/BST0351127","journal-title":"Biochem Soc Trans"},{"key":"3077_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/bpa.12137","volume":"24","author":"P Garcia-Esparcia","year":"2014","unstructured":"Garcia-Esparcia P, Llorens F, Carmona M, Ferrer I (2014) Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson\u2019s disease brain is region dependent. Brain Pathol 24:584\u2013598. doi: 10.1111\/bpa.12137","journal-title":"Brain Pathol"},{"key":"3077_CR49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397. doi: 10.1016\/S1474-4422(09)70062-6","journal-title":"Lancet Neurol"},{"key":"3077_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144. doi: 10.1016\/j.freeradbiomed.2013.01.018","journal-title":"Free Radic Biol Med"},{"key":"3077_CR51","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jvh.12521","volume":"23","author":"H-H Chen","year":"2016","unstructured":"Chen H-H, Liu PF-C, Tsai H-H, Yen R-F, Liou H-H (2016) Re: Wangensteen et al. of a letter on \u2018Hepatitis C virus infection: a risk factor for Parkinson\u2019s disease. J Viral Hepat 23:560\u2013560. doi: 10.1111\/jvh.12521","journal-title":"J Viral Hepat"},{"key":"3077_CR52","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/mds.26755","volume":"31","author":"J Kim","year":"2016","unstructured":"Kim J, Jang ES, Ok K, Oh ES, Kim KJ, Jeon B et al (2016) Association between hepatitis C virus infection and Parkinson\u2019s disease. Mov Disord 31:1584\u20131585","journal-title":"Mov Disord"},{"key":"3077_CR53","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.0000000000003848","volume":"88","author":"J Pakpoor","year":"2017","unstructured":"Pakpoor J, Noyce A, Selkihova M, Lees A (2017) Viral hepatitis and Parkinson disease: a national record-linkage study. Neurology 88:1630\u20131633","journal-title":"Neurology"},{"key":"3077_CR54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10072-016-2771-y","volume":"38","author":"RP Munhoz","year":"2017","unstructured":"Munhoz RP, Bertucci Filho D, Teive HAG (2017) Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype. Neurol Sci 38:319\u2013324. doi: 10.1007\/s10072-016-2771-y","journal-title":"Neurol Sci"},{"key":"3077_CR55","doi-asserted-by":"publisher","unstructured":"Ahmed H, Elgebaly A, Abushouk AI, Hammad AM, Attia A, Negida A (2016) Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis. Antivir Ther. doi: 10.3851\/imp3083","DOI":"10.3851\/imp3083"},{"key":"3077_CR56","doi-asserted-by":"crossref","first-page":"S508","DOI":"10.1016\/S0168-8278(17)31418-6","volume":"66","author":"H Ahmed","year":"2017","unstructured":"Ahmed H, Abushouk AI, Menshawy A, Attia A, Negida A, Loutfy SA (2017) FRI-224-ribavirin free versus ribavirin containing therapy with all second generation direct acting antivirals for the treatment of hepatitis C virus genotype 1 infection; a pooled analysis of 4501 patients. J Hepatol 66:S508\u2013S509","journal-title":"J Hepatol"},{"key":"3077_CR57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3233\/JPD-150533","volume":"5","author":"SS Bettiol","year":"2015","unstructured":"Bettiol SS, Rose TC, Hughes CJ, Smith LA (2015) Alcohol consumption and Parkinson\u2019s disease risk: a review of recent findings. J Parkinson Dis 5:425\u2013442","journal-title":"J Parkinson Dis"},{"key":"3077_CR58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","volume":"52","author":"MA Hern\u00e1n","year":"2002","unstructured":"Hern\u00e1n MA, Takkouche B, Caama\u00f1o-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease. Ann Neurol 52:276\u2013284","journal-title":"Ann Neurol"},{"key":"3077_CR59","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1212\/WNL.0000000000003853","volume":"88","author":"J Benito-Le\u00f3n","year":"2017","unstructured":"Benito-Le\u00f3n J (2017) Viral hepatitis and the risk of Parkinson disease. Neurology 88:1596\u20131597","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3077-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T20:42:16Z","timestamp":1659300136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3077-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3077"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3077-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,5]]}}}